|
|||||||||||||||||
|
EID
Home | Ahead of Print | Past
Issues | EID Search | Contact
Us | Announcements | Suggested
Citation | Submit Manuscript
Volume 10, Number 4, April 2004 Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral DrugsEmily L.C. Tan,* Eng Eong Ooi,† Chin-Yo Lin,* Hwee Cheng Tan,† Ai
Ee Ling,‡ Bing Lim,* and Lawrence W. Stanton* |
||
|
Back to article | |
Figure 2. Dose-response curves for Alferon (A), Betaferon (B), and Multiferon (C) as determined by plaque reduction assays. IC50 (50% inhibitory concentration) and IC95 (95% inhibitory concentration) values were calculated by using the fitted functions describing the curves. |
|
|
|
EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z |
|
This page last reviewed March 2, 2004 |
|
Emerging
Infectious Diseases Journal |
|